0A7L

iRhythm Technologies, Inc.

Common Stock · USD · NASDAQ

IRTCT212

Price

$115.28

+5.16%

Cap

Earnings

30d Trend

-8.0%

0A7L
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

44% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level74
Quality65
Momentum24
Technical40
Fundamentals50

Raw weighted: 41×Macro 0.99 (1%)=41

RISK

74/100
90d Volatility
44.4%High
ATR %
5.5%High daily moves
Max Drawdown (1Y)
-41.4%Volatile

QUALITY

65/100
ROE (avg)
-29.2%Negative
Piotroski F-Score
6/9Average
Debt/Equity
0.23Low leverage
Margin Stability
CV 5.8%Stable
Accruals
-12.3%Cash earnings

MOMENTUM

24/100
12-1M Momentum
-14.5%Strong downtrend
6-1M Momentum
-34.3%Negative
1M Return
-4.3%Recent pullback

TECHNICAL

40/100
RSI (14)
47.1Neutral
Price vs SMA200
-25.3%Bearish trend
MACD
-0.08Bearish momentum
Bollinger Band
40%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.084Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41
3-12 months23
1-5+ years45

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate iRhythm Technologies, Inc. at 41/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 65/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-4.3%

3 MONTHS

-13.6%

12 MONTHS

-18.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Quality (65) and Fundamentals (50) are the primary strengths. I note that momentum is the weakest area at 24/100 — this warrants monitoring. Historical volatility is elevated at 44%. I classify this as a speculative position — elevated volatility at 44% and asymmetric payoff potential define the opportunity.

speculativeScore: 41/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.